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Available online 9 January 2016Magnetic resonance imaging (MRI) is sensitive to structural and functional changes in the brain caused by
Alzheimer's disease (AD), and can therefore be used to help in diagnosing the disease. Improving classiﬁcation
of AD patients based on MRI scans might help to identify AD earlier in the disease's progress, which may be
key in developing treatments for AD. In this study we used an elastic net classiﬁer based on several measures de-
rived from the MRI scans of mild to moderate AD patients (N=77) from the prospective registry on dementia
study and controls (N=173) from the Austrian Stroke Prevention Family Study. We based our classiﬁcation on
measures from anatomical MRI, diffusion weighted MRI and resting state functional MRI. Our unimodal classiﬁ-
cation performance ranged from an area under the curve (AUC) of 0.760 (full correlations between functional
networks) to 0.909 (grey matter density). When combining measures from multiple modalities in a stepwise
manner, the classiﬁcation performance improved to an AUC of 0.952. This optimal combination consisted of
greymatter density, white matter density, fractional anisotropy, mean diffusivity, and sparse partial correlations
between functional networks. Classiﬁcation performance for mild AD as well as moderate AD also improved
whenusing thismultimodal combination.We conclude that differentMRImodalities provide complementary in-
formation for classifying AD. Moreover, combining multiple modalities can substantially improve classiﬁcation
performance over unimodal classiﬁcation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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DWI1. Introduction
Early diagnosis is key to the development of treatments for
Alzheimer's disease (AD) (Prince et al., 2011). In this respect it is well
recognised that magnetic resonance imaging (MRI) might be highly
useful as an early AD biomarker (Jack et al., 2010). Several MRI tech-
niques have been applied successfully to study average group differ-
ences between AD patients and controls in voxel based grey matter
(Ferreira et al., 2011), white matter (Li et al., 2012), diffusion measures
(Douaud et al., 2011), and functional connectivity (Gour et al., 2014;
Binnewijzend et al., 2012).
In addition to average group difference in case control studies, sim-
ilar MRI measures have also been used to predict or classify the disease
class (i.e., patient or control) of individuals. This classiﬁcation based on
MRI scans could be helpful in making a reliable diagnosis of AD in theen University, The Netherlands.
).
. This is an open access article underfuture. Machine learning classiﬁcation is a suited candidate to make
such individual predictions, because it is well equipped to handle
high-dimensional data such as those fromMRI. Reliable individual clas-
siﬁcation of AD and controls has already been achieved with MRI mea-
sures of grey matter atrophy (Klöppel et al., 2008; Plant et al., 2010;
Cuingnet et al., 2011), white matter integrity (Nir et al., 2014), and
brain activity (Lee et al., 2013; Koch et al., 2012).
Some studies suggest that classiﬁcation of Alzheimer's disease may
further improve when combining several MRI modalities (Mesrob
et al., 2012; Sui et al., 2013), while another recent study found better
classiﬁcation by using a single MRI modality (Dyrba et al., 2015). It is
not yet clear which MRI modality or combination of modalities provide
the best classiﬁcation performance of AD patients.
The goal of this study is to perform individual classiﬁcation ofmild to
moderate AD from healthy controls, and to combine information from
severalmodalities to improve this individual classiﬁcation.We compare
classiﬁcation performance for typical measures of grey matter atrophy,
whitematter integrity, and functional connectivity. Thenwe investigatethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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We test how thismultimodal classiﬁcationmodel is able to separate pa-
tients with mild AD and patients with moderate AD from healthy
controls.
2. Materials and methods
2.1. Data sample
2.1.1. Participants
Our dataset was collected as a part of the prospective registry on de-
mentia (PRODEM; see also Seiler et al., 2012). Our sample only
contained subjects scanned at theMedical University of Graz. The inclu-
sion criteria are: dementia diagnosis according to DSM-IV criteria
(American Psychiatric Association, 2000), non-institutionalisation and
no need for 24-h care, and availability of a caregiver who agrees to pro-
vide information on the patients' and his or her own condition. Patients
were excluded from the study if they were unable to sign a written in-
formed consent or if co-morbidities were likely to preclude termination
of the study. We conducted our study with the baseline scans from the
PRODEM study, and included only patients diagnosed with AD in ac-
cording the NINCDS-ADRDA Criteria (McKhann et al., 1984), for which
anatomical MRI, diffusion MRI, and resting state functional MRI scans
were present. Amyloid imaging for additional conﬁrmation of the diag-
nosis was unavailable in our sample.
The healthy controls were drawn from the Austrian Stroke Preven-
tion Family Study, which is a prospective single-centre community-
based follow-up study with the goal of examining the frequency of vas-
cular risk factors and their effects on cerebral morphology and function
in the healthy elderly. On the basis of structured clinical interview and a
physical and a neurological examination, participants had to be free of
overt neurologic or psychiatric ﬁndings and had to have no history of
a neuropsychiatric disease, including cerebrovascular attacks and de-
mentia. The study protocol was approved by the ethics committee of
the Medical University of Graz, Austria, and written informed consent
was obtained from all subjects.
This resulted in a dataset of 77 AD patients between ages 47 and 83,
of which 39 had mild AD (MMSE N 20), and 38 had moderate AD
(MMSE ≤ 20) (Perneczky et al., 2006), and 173 healthy controls be-
tween ages 47 and 83 (see Table 1).
2.1.2. MR acquisition
Each participant was scanned on a Siemens Magnetom TrioTim 3 T
MRI scanner. Anatomical T1-weighted images were acquired with
TR = 1900 ms, TE = 2.19 ms, ﬂip angle = 9, isotropic voxel size of
1 mm. Diffusion images were acquired along 12 non-collinear direc-
tions, scanning each direction 4 times with TR = 6700 ms, TE =
95 ms, 50 axial slices, voxel size = 2.0×2.0×2.5 mm. Resting-state
fMRI series of 150 volumes were obtained with TR = 3000 ms, TE =
30 ms, ﬂip angle = 90°, 40 axial slices, with an isotropic voxel size of
3 mm. We instructed participants to lie still with their eyes closed,
and to stay awake.Table 1
Demographics for the study population.
Demographics Controls Mild AD Moderate AD
Age 66.1±8.71 70.3±7.85 66.9±9.06
Gender, ♂/♀ 74/99 (57%♀) 17/22 (56%♀) 14/ 24 (63%♀)
Education (years) 11.5±2.76 11.6±3.45 10.0±2.79
Disease duration (months) 0.00±0.00 22.6±15.5 30.9±30.7
MMSE 26.7±5.80 24.2±2.07 16.6±2.73
CDR – 0.72±0.25 0.92±0.39
GDS 2.11±2.15 2.54±2.09 2.74±3.02
Data is represented asmean± standard deviation.MMSE=minimental state exam, CDR=
clinical dementia rating, GDS= geriatric depression scale.2.2. Software
TheMRI data were preprocessed using FMRIB Software Library (FSL,
version 5.0) (Smith et al., 2004; Jenkinson et al., 2012). For all further
data analyses we used MATLAB and Statistics Toolbox Release 2015b.
2.3. MRI preprocessing
The preprocessing of the anatomical MRI included brain extraction,
bias ﬁeld correction, and non-linear registration to standard MNI152
(Grabner et al., 2006). The preprocessing of the diffusion MRI included
brain extraction and correction of eddy currents. For the fMRI data the
preprocessing included brain extraction, motion correction (Jenkinson
et al., 2002), a temporal high pass ﬁlter with a cutoff point of 100 s,
and 3 mm FWHM spatial smoothing. Additionally, we used the FMRIB's
ICA-based Xnoiseiﬁer (FIX, version 1.06), with the included standard
training data to automatically identify and remove noise components
from the fMRI time course (Salimi-Khorshidi et al., 2014).
2.4. Anatomical atlases
In order to compare properties across subjects we used two anatom-
ical atlases (Fig. 1) included in FSL. For grey matter regions we used theFig. 1. Anatomical atlases overlaid on MNI brain template. Left part shows the Harvard–
Oxford cortical and subcortical areas. Right part shows the JHU white-matter
tractography atlas. The images are thresholded at 25%, and showing the area with the
maximum probability for displaying purposes, but the atlases were treated as
probabilistic in our analyses.
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2006). Each brain region in this atlas consist of a probability map,
where each voxel is assigned a probability of being part of each region.
We split the 48 cortical regions of theHarvard–Oxford atlas into left and
right hemisphere regions, resulting in 96 cortical regions. The cortical
regions were combined with the 14 brain regions from the subcortical
atlas, excluding the brain stem because it was not fully scanned for
each participant. This resulted in a total of 110 grey matter anatomical
regions. For the white matter regions we deﬁned 20 white matter re-
gions using the probabilistic JHU white-matter tractography atlas
(Hua et al., 2008). All voxels under 25% probability per region were re-
moved from each of the 110 grey matter, and each of the 20 whitemat-
ter regions. For the analyses we used the voxel-wise probabilities that
survived the thresholding for each region.
2.5. Anatomical features
We identiﬁed anatomical features by calculating the grey matter
density (GMD), and white matter density (WMD) for each brain voxel
(Zhang et al., 2001). For the GMD, we averaged the voxel-wise values
for each of the 110 grey matter regions weighted by the voxel-wise re-
gion probability. This provided a measure of brain atrophy within grey
matter regions. For theWMD,we averaged the voxel-wise values across
each of the 20 white matter regions, weighted by voxel-wise region
probability. This resulted in a feature vector of 110 average GMDs per
subject, and a feature vector of 20 average WMDs per subject.
2.6. Diffusion features
We calculated the fractional anisotropy (FA) and mean diffusivity
(MD) values for each voxel with dtiﬁt (Basser et al., 1994). Then we av-
eraged those values for each of the 20 white matter regions, weighted
by the region probability, and partial volume corrected with the
WMD, resulting in feature vectors of 20 mean FA and MD values per
subject.
2.7. Functional connectivity features
We performed temporal concatenation independent component
analysis (ICA) (Beckmann and Smith, 2004) with a relatively high di-
mensionality ﬁxed at 70 components in order to get a more reﬁned di-
vision of functionally coherent areas than with low dimensional ICA
(Beckmann, 2012; Smith et al., 2013). We used an ICA threshold of
0.99, meaning that each voxel included in the ICA map was 99 times
more likely to be part of the component than to be caused by the Gauss-
ian background noise. Then we calculated the mean time courses for
each component for each subject, weighted by the ICA weight map,
and partial volume corrected with GMD.
For each component we determined the functional connectivity
with every other component. We deﬁned the functional connectivity
as the full correlations (FC) or as a sparse L1-regularised partial correla-
tions (PC) between the components' time courses.We calculated the PC
using the graphical lasso algorithm (Friedman et al., 2008), with λ=
100 (Smith et al., 2011). Both functional connectivitymeasures resulted
in a feature vector of 70692 ¼ 2415 (partial) correlations.
2.8. Elastic net classiﬁcation with nested cross validation
We used the aforementioned six feature vectors from the three mo-
dalities with a logistic elastic net regression for classiﬁcation (Zou and
Hastie, 2005; Friedman et al., 2010). We used 10-fold cross validation
to determine the generalisation performance of an elastic net regression
models. For each subject this produced a predicted value between 0 and
1, where 0 represents a control subject and 1 represents an AD patient.The elastic net regression procedure estimates a sparse regression
model by imposing a penalty for including features and for the weight
of each feature, so that only a subset of the features are included. To de-
termine the parameters for the optimal size of this penalty without
overestimating the classiﬁcation performance we used an additional
nested cross validation loop (Varma and Simon, 2006; Kriegeskorte
et al., 2009). In the outer loop we performed 10-fold cross validation,
where 9/10th of the total dataset served as training set, and 1/10th as
test set. Then we performed a nested, 10-fold cross validation on the
training set over a grid of parameters to determine the penalty. We
used the penalty parameters that resulted in the lowest binomial devi-
ance in the nested loop to train the model on the original training set.
This model was used to make predictions for each participant in the
test set. This procedure was repeated 10 times so that each participant
was part of the test set once. By using this approach we did not use
the test set to estimate the model, nor the penalty parameters that we
used to train the model. We also included age and sex to the model
without any penalty, so that all estimated regression coefﬁcients for
the feature weights were conditional on the age and sex of the subject.
To reduce the variability in the classiﬁcation outcome resulting from
the randompartitioning in training and test foldswe repeated the entire
classiﬁcation procedure 50 times. This allowed us to average out this
variability, and report the range of observed outcomes under different
train and test set partitioning.
2.9. Measuring classiﬁcation performance
To assess the classiﬁcation performance we performed receiver op-
erating characteristic (ROC) analyses on the estimated outcomes be-
tween 0 and 1 from the elastic net regression. We calculated the ROC
curve by shifting the threshold for classifying an individual as AD from
0 to 1, and plotted the true positive rate (sensitivity) versus the false
positive rate (1 — speciﬁcity) for each intermediate point. The area
under this ROC curve (AUC) is a measure of classiﬁcation performance
that is insensitive to the distribution between controls and AD patients
(Fawcett, 2006), so thatwe can take full advantage of the larger number
of controls than AD patients in our dataset. We also reported the sensi-
tivity, and speciﬁcity values corresponding to the optimal point in the
ROC curve, given an equal penalty for a false positive and a false nega-
tive prediction, and the class distribution equal to that in our sample.
Because we repeated the procedure 50 times, the reported AUCs, sensi-
tivity, and speciﬁcity values are the average over the 50 repetitions of
the cross validation procedure.
Additionally, we investigated how well the predicted outcomes
were able to separate mild AD from controls, and moderate AD from
controls. For this purpose we also assessed the ROC curves for the
mild and moderate subgroups versus controls separately.
2.10. Combining modalities
After assessing the performance for each individual modality we
combined differentmodalities in order to study possible improvements
in classiﬁcation performance. We took a forward stepwise approach
using feature concatenation to combine information from different mo-
dalities. We started with the best performing single modality feature.
For each stepwe added each of the remainingmodalities to thewinning
combination from the previous step.We assessed the classiﬁcation per-
formance for the combined modalities by determining the AUC. We
continued the procedure until each of themodalities thatwe considered
had been added.
3. Results and discussion
The classiﬁcation results are summarised in Tables 2 and 3 for the
unimodal and stepwise multimodal procedures respectively. The AUC
Table 2
Alzheimer's patients versus controls classiﬁcation. Themean,minimumandmaximumar-
ea under the ROC curve over 50 repetitions are reported, as well as the sensitivity, speci-
ﬁcity, and classiﬁcation accuracy for the optimal point in the ROC. Results are shown for
grey matter density (GMD), white matter density (WMD), fractional anisotropy (FA),
mean diffusivity (MD), full correlations between ICA components (FC), and regularised
partial correlations between ICA components (PC).Multimodal represents the best combi-
nation from step 5 of our stepwisemultimodal procedure (GMD,WMD, FA, MD, and SPC).
Modality AUC Min–max Sensitivity Speciﬁcity Accuracy
GMD 0.909 (0.901–0.915) 0.818 0.899 0.874
WMD 0.850 (0.845–0.858) 0.623 0.902 0.816
FA 0.789 (0.784–0.796) 0.547 0.885 0.781
MD 0.832 (0.823–0.840) 0.537 0.941 0.816
FC 0.760 (0.743–0.772) 0.422 0.921 0.767
PC 0.791 (0.778–0.803) 0.529 0.859 0.758
Multimodal 0.952 (0.946–0.959) 0.826 0.927 0.896
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timodal procedure is depicted in Fig. 2.
3.1. Anatomical MRI
The measures derived from the anatomical MRI scan, grey matter
density average of Harvard–Oxford regions, and white matter density
of JHU tractography regions resulted in an excellent AUC of 0.909 and
0.850 respectively (Table 2). The good classiﬁcation performance for
GMD was expected, as AD has traditionally been seen as a grey matter
atrophy disease (Frisoni et al., 2010). The classiﬁcation performance
with GMD that we found compares favourably to a recent similar
study by Dyrba et al. (2015), who found an AUC of 0.86. While our
methods were very similar, we used the Harvard–Oxford atlas to seg-
ment our data, andDyrba et al. (2015) used theAAL atlas. The difference
in atlases for segmentation, and our larger sample size might explain
the difference in classiﬁcation performance.
3.2. Diffusion weighted MRI
The measures derived from diffusion weighted MRI, fractional an-
isotropy and mean diffusivity of JHU tractography regions performed
very reasonable with an AUC of 0.789 and 0.832 respectively
(Table 2). This performance was much higher than the AUC between
0.652 and 0.720 that Mesrob et al. (2012) found with combined FA
and MD measures, but lower than the 0.86 that Dyrba et al. (2015)
found. While Mesrob et al. (2012) examined the DTI measures in grey
matter areas, Dyrba et al. (2015) and our study examined the DTI mea-
sures inwhitematter regions, which possibly explains the differences in
classiﬁcation performance.
3.3. Functional connectivity
The measures derived from resting state functional MRI resulted in
an AUC of 0.760 and 0.791 for full correlations and regularised partial
correlations between ICA components respectively (Table 2). The
higher performance of the regularised partial correlations comparedTable 3
Multimodal classiﬁcation performance for the stepwise concatenation procedure. Each
step combines the best combination from the previous step with the remaining modali-
ties. The best result occurs with the combination of GMD, FA,WMD, PC, and MD in step 5.
Step\
combined with:
GMD FA WMD PC MD FC
1: – 0.909 0.789 0.850 0.791 0.832 0.760
2: GMD – 0.933 0.930 0.926 0.932 0.922
3: GMD + FA – – 0.949 0.927 0.934 0.930
4: GMD + FA +WMD – – – 0.951 0.941 0.938
5: GMD + FA +WMD+ PC – – – – 0.952 0.939
6: GMD + FA +WMD+ PC +MD – – – – – 0.930to the full correlations is in line with the simulation study by Smith
et al. (2011). Still, this classiﬁcation performance was relatively poor
compared to 0.848 found by Koch et al. (2012), and 0.80 found by
Dyrba et al. (2015). Koch et al. (2012) found their result by examining
the correlation between ICA components that resulted in the highest
discriminative power. Because selecting this best performing correla-
tion was not part of the cross-validation loop, their ﬁnding is likely an
overestimation of the out-of-sample generalisability. Dyrba et al.
(2015) used predeﬁned components to study the correlations between
functional regions, while we used ICA on our own dataset to acquire the
components, which might partly explain differences from our ﬁndings.
3.4. Multimodal
The stepwise procedure that we used to concatenate features from
different modalities resulted in an AUC of up to 0.952 (Table 3). This re-
sult was achieved by starting the procedure with the best performing
single modality, GMD. Classiﬁcation performance improved the most
when adding FA (from 0.909 to 0.933 AUC). After that, the best im-
provement resulted from adding WMD (0.933 to 0.949 AUC). Then,
adding PC further improved classiﬁcation performance marginally
(0.949 to 0.951 AUC), which was subsequently improved marginally
again by adding MD (from 0.951 to 0.952). Adding the FC to the previ-
ous combination decreased the classiﬁcation performance compared
to the previous step (from 0.952 to 0.930 AUC). The resulting best mul-
timodal model containing GMD, FA, WMD, PC, and MD performed well
above any of the modalities separately (Fig. 2).
Our ﬁndings are in contrast with the study of Dyrba et al. (2015),
who did not ﬁnd any improved performance by combining similarmea-
sures derived from the same MRI modalities. This difference is possibly
explained by our larger sample size, allowing many more training ex-
amples in each cross validation fold. Additionally, they used a multi-
kernel support vector machine to combine information from different
modalities, while we used feature concatenation. Apparently the elastic
net classiﬁer that we used in this study is suited to select relevant pre-
dictors, even when the feature space increases through concatenation.
Still, more advanced methods to combine information from multiple
modalities, such as linked ICA Groves et al. (2011), may beneﬁt even
more from the additional information from multiple modalities.
3.5. Mild Alzheimer's disease and moderate Alzheimer's disease
classiﬁcation
To investigate the results of our classiﬁcation methods further we
assessed the classiﬁcation performance for mild AD and moderate AD
separately. The classiﬁcation results for mild AD versus controls and
moderate AD versus controls can be found in Tables 4 and 5
respectively.
The single modality classiﬁcation performance for moderate AD (up
to 0.933 for GMD) is substantially higher than it is for mild AD (up to
0.886 for GMD). The combination of GMD, FA, WMD, PC, and MD im-
proves the classiﬁcation performance for both mild AD (from 0.886 for
GMD to 0.934 for multimodal) and moderate AD (from 0.933 for GMD
to 0.971 for multimodal). This improvement is mainly due to an im-
proved sensitivity, from 0.665 to 0.721 in mild AD, and from 0.777 to
0.813 in moderate AD. At the same time the speciﬁcity also marginally
improves from 0.920 to 0.935 in mild AD, and from 0.941 to 0.956 in
moderate AD.
3.6. General discussion
In our method we tookmuch care in the generalisability of our ﬁnd-
ings by employing a nested cross validation approach. This approach as-
sured that the class outcomes of the predicted subject was not required
to be knownwhen training themodel, nor to estimate themodel's pen-
alty parameters. Furthermore, none of the feature reduction that we
Fig. 2.Receiver operating characteristic plot for all Alzheimer's disease patients, mild AD, andmoderate AD versus control for elastic net classiﬁcationwith nested cross validation, for grey
matter density (GMD), white matter density (WMD), fractional anisotropy (FA), mean diffusivity (MD), full correlation between independent components (FC), and regularised partial
correlation between independent components (PC). Multimodal represents the best combination from step 5 of our stepwise multimodal procedure (GMD, WMD, FA, MD, and PC).
The diagonal line represents random classiﬁcation performance.
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would result in overestimation of classiﬁcation performance. Instead
we reduced dimensionality by relying on anatomical atlases for the an-
atomical and diffusion features, and on data-driven unsupervised learn-
ing of independent components for the functional features. Further
feature reduction was conducted in the model training phase by the
elastic net classiﬁer. Again the feature reduction in this phase did not
rely on class differences in the test subjects, but only in the training sub-
jects. Additionally, because of the relatively large sample size that we
used the results were very reliable over different iterations of the
cross validation procedure, increasing our conﬁdence that the results
of the procedure generalise well.
Interestingly, themultimodal procedure resulted in the best classiﬁ-
cation performance when all modalities were combined, except for the
full correlation between ICA components. The partial correlations,
which were based off of the same components' time-courses, were
part of the best multimodal combination. Apparently, the full correla-
tions did not add information to the classiﬁcation model over what
the partial correlations did.
The improvement in classiﬁcation performance in the multimodal
case over the best single modality measure was substantial, especially
given the relatively good performance for grey matter density. We
found this multimodal improvement in both the mild AD as well as
themoderate AD group. Therefore we are optimistic that these ﬁndings
will apply to even earlier stages of dementia as well.
3.7. Limitations
While we expect that our cross validation procedure ensured good
generalisability of the classiﬁcation performance, the models that
were trained to predict each subject rely heavily on both random and
non-random class differences in the training sample. Therefore weTable 4
Mild AD versus controls classiﬁcation. Multimodal represents the best combination from
step 5 of our stepwise multimodal procedure (GMD, FA, WMD, PC, and MD).
Modality AUC min–max Sensitivity Speciﬁcity Accuracy
GMD 0.886 (0.878–0.897) 0.665 0.920 0.873
WMD 0.841 (0.829–0.851) 0.564 0.926 0.859
FA 0.783 (0.779–0.790) 0.287 0.974 0.848
MD 0.838 (0.832–0.844) 0.369 0.993 0.878
COR 0.728 (0.706–0.751) 0.183 0.966 0.822
SPC 0.770 (0.737–0.796) 0.176 0.969 0.823
Multimodal 0.934 (0.927–0.944) 0.721 0.935 0.896cannot reliably differentiate between real and random class differences
in the trained models, which is the reason that we have refrained from
biological interpretation of model parameters.
Furthermore, even though the general trend in our multimodal pro-
cedure suggests that there is added information gained from combining
multiple modalities, it is sometimes difﬁcult to draw hard conclusions
about which modality improves the classiﬁcation the most. For exam-
ple, the improvement from adding FA to GMD resulted in an AUC of
0.933, but adding MD instead resulted in an AUC of 0.932. It would be
naive to conclude that the combination of GMD and FA performs better
than the combination of GMD and MD. Still, the general ﬁnding is that
combiningmodalities with decent individual classiﬁcation performance
improves the classiﬁcation. More ﬁndings from similar research should
shed light onwhatmeasures result in themost powerful combination to
classify AD. Overall the elastic net classiﬁcation model is very well suit-
able to build a good model when many features from different modali-
ties are added, which is why the combination of all features, except full
correlations, resulted in optimal classiﬁcation.
In our procedure we have made some choices that could affect the
results. We chose the Harvard Oxford atlas to parcellate GMD, and the
JHU tracts to parcellate WMD and diffusion measures. Different atlases
for parcellation might have produced slightly different results. The 70-
dimensionality ICA fromwhich we derived areas for functional connec-
tivity was chosen because they produce amore ﬁne grained representa-
tion of functional areas than lower dimensionality ICA. However, the
dimensionality of the ICA is a trade-off between detail in the functional
areas and the number of correlations, and it is not known what dimen-
sionality is optimal in this trade-off.
The question remains howwell our results generalise to caseswhere
the patients' symptoms are less severe, such as inmild cognitive impair-
ment, as well as to early AD diagnosis. The procedures used in this re-
search could serve as a starting point to answer these questions.Table 5
Moderate AD versus controls classiﬁcation. Multimodal represents the best combination
from step 5 of our stepwise multimodal procedure (GMD, FA, WMD, PC, and MD).
Modality AUC Min–max Sensitivity Speciﬁcity Accuracy
GMD 0.933 (0.924–0.942) 0.777 0.941 0.912
WMD 0.860 (0.853–0.866) 0.515 0.936 0.860
FA 0.794 (0.787–0.804) 0.361 0.978 0.867
MD 0.826 (0.811–0.839) 0.447 0.974 0.879
COR 0.793 (0.769–0.823) 0.465 0.944 0.858
SPC 0.812 (0.795–0.829) 0.349 0.956 0.847
Multimodal 0.971 (0.964–0.975) 0.813 0.956 0.930
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In our study we found that combining information from anatomical
MRI, diffusion weighted MRI, and resting state functional MRI can im-
prove AD classiﬁcation performance for both mild AD and moderate
AD. The best combination in our study consisted of the average grey
matter density over anatomical regions, fractional anisotropy, mean dif-
fusivity, and white matter density over white matter tracts, and
regularised partial correlations between ICA components. When only
a singlemodality can be considered for classiﬁcation, greymatter densi-
ty consistently results in the best classiﬁcation performance. However,
when available there is a clear beneﬁt from incorporating anatomical
MRI, diffusion weighted MRI, and resting state functional MRI for diag-
nostic purposes. Therefore, we recommend thatMRI scanning protocols
designed for diagnosis of Alzheimer's disease collect structural, diffu-
sion, and functionalMRI. Furthermore,we found that an elastic net clas-
siﬁer is well suited to estimate a predictive model when features from
different modalities are combined by simple concatenation.
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